A SPECTRUM OF ORGAN SYSTEMS THAT RESPOND TO CANCER: THE JOINTS AND CONNECTIVE TISSUE

J. A. Mills

DOI: https://doi.org/10.1111/j.1749-6632.1974.tb14478.x

IF: 6.499

1974-03-01

Annals of the New York Academy of Sciences

Abstract:The interest in an association between cancer and connective tissue disease stems from the insights that such an association might provide into the pathogenesis of these diseases. Although this seems to be a case of the blind leading the blind, the situation still merits a careful analysis. The known syndromes can be placed into one of two categories, based on the apparent relationship between the onsets and subsequent courses of the component diseases. I will bypass the clinical conditions caused by direct tumor invasion of muscles or joints. Some of these are encountered relatively frequently and can cause diagnostic problems; however, this mechanism is not germane to the present discussion. The first category is that in which the rheumatic disease begins after the neoplasm has presumptively started, even though the tumor does not become evident until later. The time relationship suggests that the cancer somehow initiates the connective tissue disease. The disease associations that seem to fulfill these conditions are shown in TABLE 1. It is important to the rheumatologist that in each case the clinical features of the connective tissue disease are indistinguishable from those encountered in uncomplicated cases. Presumptively, the pathogenesis of the isolated and tumor-associated conditions is similar. A number of other associations between connective tissue disease and cancer have been reported.' It is important to bear in mind that certain of these diseases are relatively common, and it is probable that the frequency of coincidence does not exceed that dictated by chance. Dermatomyositis is the most dramatic of the first group of syndromes. Although it may occur in association with tumors at any age, it is particularly prone to develop in later life. The converse relationship is even more striking in that the peak incidence of uncomplicated dermatomyositis is prior to the fifth decade, and cases that begin after age 50 are associated almost always with malignancy.' This age-related incidence should tell us something. Perhaps the older individual is more prone to dermatomyositis, but some factor important in the pathogenesis of sporadic disease is missing in later life and is supplied by the tumor. This seems more probable than one major alternative: that is, the tumor that appears after age 50 is qualitatively different in some way that is responsible for the complication. Another attractive hypothesis is that the host response to the tumor is different in older age and that this response rather than the tumor itself is the cause of dermatomyositis. Because of the prompt improvement in the dermatomyositis that occurs when the tumor is successfully treated, the tumor must be continuously synthesizing or stimulating the production of the pathogenic factor. Several groups who have studied patients with the dermatomyositis syndrome have demonstrated cutaneous reactivity to an aqueous tumor extract and have passively transferred such reactivity with serum.2 This observation argues strongly in favor of an antibody-mediated immunological response to the tumor but tells us little about the pathogenesis of the dermatomyositis. One possibility is that